Elsevier/Lancet launch H1N1 resource centre

An H1N1 influenza channel has been added to the Elsevier Global Medical News (EGMN) wire service division of the International Medical News Group. The H1N1 channel was created to meet physicians' continuing needs to keep up-to-date with the news about the spread of the 2009 H1N1 influenza virus, as well as the new diagnostics, vaccines, clinical trials, and treatments for H1N1 infections. 

"Rapid dissemination of H1N1 news will be essential to physicians during this pandemic. EGMN wants to assure its clients that physicians will look to them for the latest H1N1 developments," said Alan Imhoff, president and publisher of the International Medical News Group.

Elsevier Global Medical News is the daily syndicated medical news wire service of the International Medical News Group (IMNG), which has a 40-year history of success in providing medical specialty news. The EGMN division was launched in January 2006 and its syndicated news now appears in 30 countries as part of its clients’ websites and intranet and is the medical specialty news provider to Elsevier's MDConsult, MedConnect, and OncologySTAT. Offering original news written for physicians and divided into therapeutic areas or “channels,” EGMN is produced by more than 60 journalists with on-site reporting from over 450 medical meetings, breaking news, journal summaries, and feature stories from medical experts. 

EGMN’s H1N1 news content is also available on the Lancet’s H1N1 site, www.thelancet.com/H1N1-flu. The Lancet's H1N1 Resource Centre is the result of a collaborative effort by the editors of over 40 Elsevier-published journals and 11 learned societies who have agreed to make freely available on this site any relevant content.

http://egmn.idsk.com/index.jsp and http://www.thelancet.com/H1N1-flu

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Elevated antibody responses to Epstein-Barr virus linked to increased risk of multiple sclerosis